Beclin1 and Bcl-xL expressions could be evaluated successfully and simultaneously in 230 epithelial ovarian tumors (including 26 cystadenomas, 35 borderline tumors and 169 invasive carcinomas) of the TMA constructed previously and in 12 normal ovaries. The gene discussed is BCL2L1; the disease is ovarian epithelial tumor.